European Companies Search Engine

EU funding (€6,478,738): Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF) Hor15 Dec 2016 EU Research and Innovation programme "Horizon"

Overview

Text

The filing refers to a past date, and does not necessarily reflect the current state.

Creative Commons License The visualizations for "ALBUTEC GmbH - EU funding (€6,478,738): Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF)" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.